AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Ravaglia, G.
Right arrow Articles by Mecocci, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravaglia, G.
Right arrow Articles by Mecocci, P.
Agricola
Right arrow Articles by Ravaglia, G.
Right arrow Articles by Mecocci, P.
American Journal of Clinical Nutrition, Vol. 87, No. 5, 1306-1313, May 2008
© 2008 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort1,2,3

Giovanni Ravaglia, Paola Forti, Anna Lucicesare, Nicoletta Pisacane, Elisa Rietti, Francesca Mangialasche, Roberta Cecchetti, Christopher Patterson and Patrizia Mecocci

1 From the Department of Internal Medicine, Cardioangiology, and Hepatology, University Hospital Sant'Orsola-Malpighi, University of Bologna, Bologna, Italy (GR, PF, AL, NP, and ER); the Institute of Gerontology and Geriatrics, Perugia University Hospital, Perugia, Italy (FM, RC, and PM); and the Department of Medicine, McMaster University, Hamilton, ON, Canada (CP)

Background: Evidence that vitamin E may preserve cognitive function in elderly subjects is conflicting. The most abundant and most investigated form of vitamin E in humans is {alpha}-tocopherol, but other antioxidant tocopherols (β, {gamma}, and {delta}) exist in nature.

Objective: We aimed to investigate plasma concentrations of the natural tocopherols and the tocopherol oxidation markers {alpha}-tocopherylquinone ({alpha}TQ) and 5-nitro-{gamma}-tocopherol (5NGT) in relation to cognitive function in the elderly.

Design: Baseline plasma tocopherols and their oxidation markers were measured in 761 elderly Italian subjects from a population-based cohort assessed in 1999–2000 for mild cognitive impairment (MCI) and dementia. In 2003–2004, information about cognitive status was collected for 615 of the 666 subjects without baseline cognitive impairment. Tocopherols and oxidation markers were analyzed as plasma absolute values divided by serum total cholesterol because lipids affect their blood availability. Analyses were adjusted for sociodemographic, genetic, lifestyle, and medical confounders.

Results: Compared with the corresponding lowest tertile, the risk of prevalent dementia was higher for the highest tertile of {delta}-tocopherol÷cholesterol [odds ratio (OR): 3.87; 95% CI: 1.46, 10.27] and {alpha}TQ÷cholesterol (4.02; 1.45, 11.14), but the risk of incident dementia was not directly associated with plasma vitamin E metabolites. A U-shaped association, with lower risk for intermediate tertiles, was found for prevalent MCI with 5NGT÷cholesterol (0.39; 0.17, 0.91) and for incident dementia with {gamma}-tocopherol÷cholesterol (hazard ratio: 0.42; 95% CI: 0.22, 0.84).

Conclusions: Plasma concentrations of some non-{alpha}-tocopherol forms of vitamin E are associated with cognitive impairment in elderly people. However, the associations depend on concurrent cholesterol concentration and need further investigation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition